论文部分内容阅读
为了增加药物在肿瘤局部的浓度并提高其透入瘤细胞膜的速率,由静脉内发展到动脉内“顺二氯化二氨亚铂”(Cis-platinum)(以下简称“顺铂”)灌注治疗骨肿瘤已取得初步成效。
In order to increase the local concentration of the drug in the tumor and increase its rate of penetration into the tumor’s cell membrane, the infusion of intravenous Cis-platinum (Cisplatinum) (hereinafter referred to as “cisplatin”) into the artery Bone tumors have achieved initial results.